Clinical trials
Active, not recruiting Phase 4 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2015 | 2 |
| 2019 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| GlaxoSmithKline | 3 |
| Pfizer | 2 |
| Astellas Pharma Inc | 1 |
| Kumamoto University | 1 |
| National Center for Global Health and Medicine, Japan | 1 |
| Saga University | 1 |
| Takeshi Morimoto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Heart Failure | 2 |
| Astrocytoma | 1 |
| Autoimmune Diseases | 1 |
| Breast Neoplasms | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Coronary Artery Disease | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Edema | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.